Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010–2015 | Zendy

Katie J. Suda | Zendy; Lauri A. Hicks | Zendy; Rebecca M. Roberts | Zendy; Robert J. Hunkler | Zendy; Linda M. Matusiak | Zendy; Glen T. Schumock | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010–2015

Author(s) -

Katie J. Suda,

Lauri A. Hicks,

Rebecca M. Roberts,

Robert J. Hunkler,

Linda M. Matusiak,

Glen T. Schumock

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix773

Subject(s) - medicine , health care , antibiotics , environmental health , family medicine , economic growth , microbiology and biotechnology , economics , biology

Improving antibiotic use has the potential to decrease healthcare costs by reducing the incidence of antibiotic-resistant infections, antibiotic-associated adverse events, and expenditures due to unnecessary prescriptions. Antibiotic expenditures in 2009 totaled $10.7 billion in the United States. Since then, national and local antibiotic stewardship initiatives have grown. The purpose of this study was to assess trends in antibiotic expenditures by healthcare setting in the United States between 2010 and 2015.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research